Genetic profiling of protein burden and nuclear export overload

  1. Reiko Kintaka
  2. Koji Makanae
  3. Shotaro Namba
  4. Hisaaki Kato
  5. Keiji Kito
  6. Shinsuke Ohnuki
  7. Yoshikazu Ohya
  8. Brenda J Andrews
  9. Charles Boone
  10. Hisao Moriya  Is a corresponding author
  1. University of Toronto, Canada
  2. Okayama University, Japan
  3. Meiji University, Japan
  4. University of Tokyo, Japan

Abstract

Overproduction (op) of proteins triggers cellular defects. One of the consequences of overproduction is the protein burden/cost, which is produced by an overloading of the protein synthesis process. However, the physiology of cells under a protein burden is not well characterized. We performed genetic profiling of protein burden by systematic analysis of genetic interactions between GFP-op, surveying both deletion and temperature-sensitive mutants in budding yeast. We also performed genetic profiling in cells with overproduction of triple-GFP (tGFP), and the nuclear export signal-containing tGFP (NES-tGFP). The mutants specifically interacted with GFP-op were suggestive of unexpected connections between actin-related processes like polarization and the protein burden, which was supported by morphological analysis. The tGFP-op interactions suggested that this protein probe overloads the proteasome, whereas those that interacted with NES-tGFP involved genes encoding components of the nuclear export process, providing a resource for further analysis of the protein burden and nuclear export overload.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Reiko Kintaka

    Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. Koji Makanae

    Research Core for Interdisciplinary Sciences, Okayama University, Kita-ku, Okayama, Japan
    Competing interests
    The authors declare that no competing interests exist.
  3. Shotaro Namba

    Matching Program Course, Okayama University, Okayama, Japan
    Competing interests
    The authors declare that no competing interests exist.
  4. Hisaaki Kato

    Graduate School of Environmental and Life Science, Okayama University, Okayama, Japan
    Competing interests
    The authors declare that no competing interests exist.
  5. Keiji Kito

    Department of Life Sciences, School of Agriculture, Meiji University, Kawasaki, Japan
    Competing interests
    The authors declare that no competing interests exist.
  6. Shinsuke Ohnuki

    Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan
    Competing interests
    The authors declare that no competing interests exist.
  7. Yoshikazu Ohya

    Graduate School of Frontier Sciences, University of Tokyo, Kashiwa, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0837-1239
  8. Brenda J Andrews

    Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  9. Charles Boone

    Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Hisao Moriya

    Research Core for Interdisciplinary Sciences, Okayama University, Kita-ku, Okayama, Japan
    For correspondence
    hisaom@cc.okayama-u.ac.jp
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7638-3640

Funding

Japan Society for the Promotion of Science (17H03618)

  • Hisao Moriya

Japan Society for the Promotion of Science (15KK0258)

  • Hisao Moriya

Japan Society for the Promotion of Science (18K19300)

  • Hisao Moriya

Japan Society for the Promotion of Science (20H03242)

  • Hisao Moriya

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Kintaka et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,851
    views
  • 256
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Reiko Kintaka
  2. Koji Makanae
  3. Shotaro Namba
  4. Hisaaki Kato
  5. Keiji Kito
  6. Shinsuke Ohnuki
  7. Yoshikazu Ohya
  8. Brenda J Andrews
  9. Charles Boone
  10. Hisao Moriya
(2020)
Genetic profiling of protein burden and nuclear export overload
eLife 9:e54080.
https://doi.org/10.7554/eLife.54080

Share this article

https://doi.org/10.7554/eLife.54080

Further reading

    1. Genetics and Genomics
    Shaohua Gu, Yuanzhe Shao ... Zhiyuan Li
    Research Article

    Microbial secondary metabolites are a rich source for pharmaceutical discoveries and play crucial ecological functions. While tools exist to identify secondary metabolite clusters in genomes, precise sequence-to-function mapping remains challenging because neither function nor substrate specificity of biosynthesis enzymes can accurately be predicted. Here, we developed a knowledge-guided bioinformatic pipeline to solve these issues. We analyzed 1928 genomes of Pseudomonas bacteria and focused on iron-scavenging pyoverdines as model metabolites. Our pipeline predicted 188 chemically different pyoverdines with nearly 100% structural accuracy and the presence of 94 distinct receptor groups required for the uptake of iron-loaded pyoverdines. Our pipeline unveils an enormous yet overlooked diversity of siderophores (151 new structures) and receptors (91 new groups). Our approach, combining feature sequence with phylogenetic approaches, is extendable to other metabolites and microbial genera, and thus emerges as powerful tool to reconstruct bacterial secondary metabolism pathways based on sequence data.

    1. Cancer Biology
    2. Genetics and Genomics
    Joakim W Karlsson, Vasu R Sah ... Jonas A Nilsson
    Research Article

    Uveal melanoma (UM) is a rare melanoma originating in the eye’s uvea, with 50% of patients experiencing metastasis predominantly in the liver. In contrast to cutaneous melanoma, there is only a limited effectiveness of combined immune checkpoint therapies, and half of patients with uveal melanoma metastases succumb to disease within 2 years. This study aimed to provide a path toward enhancing immunotherapy efficacy by identifying and functionally validating tumor-reactive T cells in liver metastases of patients with UM. We employed single-cell RNA-seq of biopsies and tumor-infiltrating lymphocytes (TILs) to identify potential tumor-reactive T cells. Patient-derived xenograft (PDX) models of UM metastases were created from patients, and tumor sphere cultures were generated from these models for co-culture with autologous or MART1-specific HLA-matched allogenic TILs. Activated T cells were subjected to TCR-seq, and the TCRs were matched to those found in single-cell sequencing data from biopsies, expanded TILs, and in livers or spleens of PDX models injected with TILs. Our findings revealed that tumor-reactive T cells resided not only among activated and exhausted subsets of T cells, but also in a subset of cytotoxic effector cells. In conclusion, combining single-cell sequencing and functional analysis provides valuable insights into which T cells in UM may be useful for cell therapy amplification and marker selection.